Información del autor
Autor Moore, D. a. J. |
Documentos disponibles escritos por este autor (3)
Añadir el resultado a su cesta Hacer una sugerencia Refinar búsqueda
texto impreso
Pope, V. ; Sacksteder, K. A. ; Hererra, J. Coronel ; Gilman, R. H. ; Vargas-Prada, S. ; Lopez Romero, S. ; Yafac, J. ; Sanchez Rios, E. ; Moore, D. a. J. | International Union Against Tuberculosis and Lung Disease | 2018-11-30T17:17:16ZSETTING: There remains a lack of effective and inexpensive diagnostic tools for active tuberculosis (TB) disease. Testing immune responses to proteins secreted by Mycobacterium tuberculosis, such as MPT64, may be a diagnostic option. OBJECTIVE: [...]texto impreso
Obregón, G. ; Zevallos, K. ; Alarcón, V. ; Puyén, Z. M. ; Chávez Inagaki, O. ; Mendoza-Ticona, A. ; Alarcón-Arrascue, E. ; Heldal, E. ; Moore, D. a. J. | International Union Against Tuberculosis and Lung Disease | 2018-11-30T22:50:36ZSETTING: The detection of multidrug-resistant tuberculosis (MDR-TB) using rapid drug susceptibility testing (DST) has increased steadily in recent years in Peru, from 9216 tests in 2010 to 27 021 tests in 2015. Research examining the impact of r[...]texto impreso
Coronel, J. ; Roper, M. H. ; Herrera, C. ; Bonilla, C. ; Jave, O. ; Gianella, C. ; Sabogal, I. ; Huancare, V. ; Leo, E. ; Tyas, A. ; Mendoza-Ticona, A. ; Caviedes, L. ; Moore, D. a. J. | Elsevier | 2020-06-10T18:11:31ZDrug susceptibility testing (DST) is often needed in patients clinically failing tuberculosis (TB) therapy. Most studies of phenotypic direct drug susceptibility tests, such as microscopic observation drug susceptibility (MODS) tests, have bee[...]